Literature DB >> 20379797

The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity.

Melania Manco1, José Manuel Fernandez-Real, Fabio Maria Vecchio, Valerio Vellone, José María Moreno, Vincenzo Tondolo, GianFranco Bottazzo, Giuseppe Nanni, Geltrude Mingrone.   

Abstract

BACKGROUND: Innate immune system participates actively into inflammatory processes, with immune cells and liver secreting a number of immune peptides. Among them, both soluble CD14 receptor (sCD14) and human neutrophil alpha-defensins (HNDs) may represent serum markers of necro-inflammation in obese patients with non-alcoholic fatty liver disease.
METHODS: To verify this hypothesis, we investigated changes in circulating levels of sCD14 and HNDs in 11 severely obese young women following surgery-induced weight loss (bilio-pancreatic diversion). Patients were evaluated before surgery and 2 years later, with NAS score evaluated on liver biopsies and whole body glucose uptake (M value) by euglycemic hyperinsulinemic clamp.
RESULTS: NAS score improved in nine patients [median NAS score in the whole sample, 6 (5-6) vs. 3 (3-4), p = 0.016]. Serum concentrations of HNDs decreased significantly in all (p = 0.016), whilst sCD14 increased only in the nine women who showed the amelioration of the NAS score [2.4 (1.7-2.6) vs. 2.6 (2.3-3.3) μg/ml, p = 0.001]. NAS score and HNDs correlated significantly both before (r(o) = 0.671, p = 0.02) and after weight loss (r(o) = 0.683, p = 0.029), NAS score and sCD14 only before surgery (r(o) = 0.605, p = 0.04). The M value increased in all patients [2.67 (1.99-3.01) vs. 6.89 (6.35-7.32) mg kg (FFM)(-1)min(-1); p = 0.01], but independently of NAS score changes.
CONCLUSIONS: Changes in levels of HNDs and sCD14 accompany those in hepatic necro-inflammation due to surgical-induced weight loss. Further studies are needed to verify any causative role of these peptides in non-alcoholic steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379797     DOI: 10.1007/s11695-010-0129-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  51 in total

1.  Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, > or =30).

Authors:  Iftikhar J Kullo; Donald D Hensrud; Thomas G Allison
Journal:  Am J Cardiol       Date:  2002-06-15       Impact factor: 2.778

2.  Circulating soluble CD14 monocyte receptor is associated with increased alanine aminotransferase.

Authors:  José Manuel Fernández-Real; Abel López-Bermejo; Montserrat Broch; Joan Vendrell; Cristobal Richart; Wifredo Ricart
Journal:  Clin Chem       Date:  2004-08       Impact factor: 8.327

Review 3.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

4.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-06       Impact factor: 2.571

5.  Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure.

Authors:  S B Heymsfield; S Lichtman; R N Baumgartner; J Wang; Y Kamen; A Aliprantis; R N Pierson
Journal:  Am J Clin Nutr       Date:  1990-07       Impact factor: 7.045

6.  Leptin pulsatility in formerly obese women.

Authors:  Geltrude Mingrone; Melania Manco; Luigi Granato; Menotti Calvani; Antonio Scarfone; Elena Valera Mora; Aldo V Greco; Hubert Vidal; Marco Castagneto; Eleuterio Ferrannini
Journal:  FASEB J       Date:  2005-06-13       Impact factor: 5.191

7.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

8.  Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

Authors:  Samuel Klein; Bettina Mittendorfer; J Christopher Eagon; Bruce Patterson; Lafaine Grant; Nikki Feirt; Ekihiro Seki; David Brenner; Kevin Korenblat; Jennifer McCrea
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

Review 9.  Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids.

Authors:  Joo Y Lee; Ling Zhao; Daniel H Hwang
Journal:  Nutr Rev       Date:  2010-01       Impact factor: 7.110

Review 10.  Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.

Authors:  Ele Ferrannini; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

View more
  7 in total

1.  Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model.

Authors:  Giovanna Sociali; Mirko Magnone; Silvia Ravera; Patrizia Damonte; Tiziana Vigliarolo; Maria Von Holtey; Valerio G Vellone; Enrico Millo; Irene Caffa; Michele Cea; Marco Daniele Parenti; Alberto Del Rio; Maximilien Murone; Raul Mostoslavsky; Alessia Grozio; Alessio Nencioni; Santina Bruzzone
Journal:  FASEB J       Date:  2017-04-06       Impact factor: 5.191

Review 2.  The gut microbiota and its relationship to diet and obesity: new insights.

Authors:  Siobhan F Clarke; Eileen F Murphy; Kanishka Nilaweera; Paul R Ross; Fergus Shanahan; Paul W O'Toole; Paul D Cotter
Journal:  Gut Microbes       Date:  2012-05-01

3.  Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study.

Authors:  Stela Z Berisha; David Serre; Philip Schauer; Sangeeta R Kashyap; Jonathan D Smith
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

4.  CD14 modulates inflammation-driven insulin resistance.

Authors:  José Manuel Fernández-Real; Sofia Pérez del Pulgar; Elodie Luche; José Maria Moreno-Navarrete; Aurelie Waget; Matteo Serino; Eleonora Sorianello; Alex Sánchez-Pla; Francesc Carmona Pontaque; Joan Vendrell; Matilde R Chacón; Wifredo Ricart; Remy Burcelin; Antonio Zorzano
Journal:  Diabetes       Date:  2011-06-23       Impact factor: 9.461

5.  Greater Microbial Translocation and Vulnerability to Metabolic Disease in Healthy Aged Female Monkeys.

Authors:  Quentin N Wilson; Magan Wells; Ashley T Davis; Christina Sherrill; Matthew C B Tsilimigras; Roshonda B Jones; Anthony A Fodor; Kylie Kavanagh
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

6.  Discovery and Validation of a Novel Neutrophil Activation Marker Associated with Obesity.

Authors:  Yue Pan; Jeong-Hyeon Choi; Huidong Shi; Liwen Zhang; Shaoyong Su; Xiaoling Wang
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

Review 7.  Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.

Authors:  Joeri Lambrecht; Frank Tacke
Journal:  Front Immunol       Date:  2021-02-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.